A PHASE 2, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS

Project: Research project

Project Details

StatusFinished
Effective start/end date3/30/183/29/21

Funding

  • Pfizer, Inc.: $6,158.00